Genzyme Belgium corporate

Company Info

Who We Are

About Genzyme, a Sanofi Company

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research and with the compassion and commitment of our employees. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. That goal guides and inspires us every day. Genzyme's portfolio of transformative therapies, which are marketed in countries around the world, represents groundbreaking and life-saving advances in medicine. As a Sanofi company, Genzyme benefits from the reach and resources of one of the world's largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Learn more at

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Contact Info:

Genzyme in Geel B.V.B.A./S.P.R.L.
Cipalstraat 8
B-2440 Geel
Tel: +32 14 564 911 (central/switchboard)
Fax: +32 14 564 916

Contact Info:

Genzyme Belgium Sales & Marketing
Airport Plaza - Montreal Building
Leonardo Da Vinci laan 19
B-1831 Diegem
Tel: +32 2 710 5400
Fax: +32 2 710 5409